Dr. Samulski received his PhD in medical microbiology and immunology from the University of Florida. His graduate work (1978-82) demonstrated the first use of AAV as a viral vector and culminated in the first U.S. patent involving non-AAV genes inserted into AAV.
Current role
Chief Scientific Officer at Biomemory
SVP for Research at Penn State University
Chief Behavioral Science Officer And President Americas at Mind Gym
Chief Research & Development Officer at Fate Therapeutics
President & Chief Science Officer at NULASTIN
Access the worlds's biggest network of public org charts
Learn more